Moreover, recent data failed to show any association between nephrocalcinosis and progression of CKD in large cohorts of patients either with CLCN5 or OCRL mutations (Blanchard et al. 2016; Zaniew et al. 2018). This evidence concerns the gene CLCN5 and chronic kidney disease.